Clinical Evaluation of the SNaP Wound Care System in Promoting Healing in Chronic Wounds

Withdrawn

• Conditions: Lower Extremity Diabetic Leg Wounds; Lower Extremity Venous Leg Wounds; Lower Extremity Mixed Aetiology Leg Wounds
• Interventions: Device: SNaP® Wound Care System

• Registration Number: NCT01417208
• Lead Sponsor: KCI USA, Inc

Brief Summary

The purpose of this study is to evaluate a novel topical negative pressure (TNP) wound therapy device called the SNaP® (Smart Negative Pressure) Wound Care System for the treatment of lower extremity diabetic, venous and mixed aetiology leg wounds.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-06
• Study First Submitted: 2011-08-12
• Study First Submitted QC: 2011-08-15
• Study First Posted: 2011-08-16
• Primary Completion: 2012-12
• Study Completion: 2012-12
• Status Verified: 2024-11
• Last Update Submitted: 2024-11-21
• Last Update Posted: 2024-11-25

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Patient has diabetic foot ulceration, venous ulcer, or mixed aetiology ulcer with a surface area <100 cm2 and <10 cm in widest diameter on lower extremity, but larger than 1 cm2 (venous and mixed aetiology ulcers will be defined by clinical exam of treating physician. Diabetic foot ulcers will be defined by clinical exam of the treating physician and as lower extremity ulcers in patients with a diagnosis of diabetes, but without venous stasis disease).
• Wound present for >30 days.
• Patient has wound in location amenable to creation of airtight seal around wound using TNP dressings.
• Patient is able to comply with study protocol requirements.
• Patient is able to understand and provide written consent.

Exclusion Criteria

• Patient has evidence of wound infection in the opinion of the physician.
• Patient has a thick eschar that persists after wound debridement.
• Patient has an HbA1C >12%.
• Patient has ulcers due to inflammatory conditions such as pyoderma gangrenosum, rheumatoid arthritis, vasculitis, cryoglobulinaemia, necrobiosis lipoidica, panniculitis, lupus erythematosus, scleroderma, or calcinosis.
• Patient has untreated osteomyelitis.
• Patient has any other condition that, in the opinion of the investigator, makes the patient inappropriate to take part in this study.
• Patient is allergic to the wound care device or occlusive dressing.
• Patient has exposed blood vessels.
• Patient is pregnant or pregnancy is suspected.
• Patient is actively participating in other clinical trials that may interfere with their participation in this study.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
SNaP® Wound Care System	SNaP® Wound Care System	-

Primary Outcome Measures

Name	Time	Method
Wound Closure	12 weeks

Trial Locations

Locations (1)

Section of Wound Healing; 🇬🇧 Cardiff, Wales, United Kingdom